Your browser doesn't support javascript.
loading
Overcoming proteasome inhibitor resistance in the immunotherapy era.
Patiño-Escobar, Bonell; Talbot, Alexis; Wiita, Arun P.
Affiliation
  • Patiño-Escobar B; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Talbot A; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; INSERM U976, Institut de Recherche Saint Louis, Université de Paris, Paris, France.
  • Wiita AP; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA; Chan Zuckerberg Biohub San Francisco, San Francisco, CA, USA. Electronic address: Arun.wiita@ucsf.edu.
Trends Pharmacol Sci ; 44(8): 507-518, 2023 08.
Article in En | MEDLINE | ID: mdl-37344251
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteasome Inhibitors / Multiple Myeloma Limits: Humans Language: En Journal: Trends Pharmacol Sci Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteasome Inhibitors / Multiple Myeloma Limits: Humans Language: En Journal: Trends Pharmacol Sci Year: 2023 Document type: Article